Each testing method has its own limitations. Urine reflects recent exposure, while meconium and cord tissue can capture longer-term exposure during pregnancy. Understanding the differences helps providers choose the right approach for accurate assessment and timely care.

Free CE webinar for healthcare & public health professionals. Hosted by @healthyKY | Featuring Dr. Dawn Forbes, NASCEND. 🎓 1.5 CE credits. 🔗 Register:

Medicaid is the nation’s leading payer of care for newborns with neonatal opioid withdrawal syndrome (NOWS). Any changes to how that care is supported could impact access to treatment for these infants.

Myth! 🔎 Studies indicate that prenatal marijuana exposure is associated with reduced attention skills, with effects appearing to be more significant in girls compared to boys.

<20% of moms w/ OUD provide breastmilk despite its power to ease withdrawal & support bonding. What’s getting in the way?. Join us at #AWHONN 2025 for Nourishing Bonds w/ Dr. Forbes + Dixie Weber to explore how we can do better. 🔗 #AWHONN2025

Cracking the code to successful feeding in OEI starts with the right tools:.🍼 Nutrition strategies. 🎶 Music & regulation techniques. 👩‍👧 Engaged, supported parents. We’re bringing all of this to AWHONN 2025. Will you be there? Let’s connect:

Gastrointestinal withdrawal impacts:.🥣 Nutrition | 📈 Growth | 🧠 Brain | 💞 Bonding | 🫂 Outcomes. Join Dr. Forbes at #AWHONN2025 to explore nutrition & person-centered care for OEI.

Think crying is the #1 symptom that leads to treatment for opioid-exposed infants?.❌ Not crying.❌ Not tremors.�� It’s poor feeding—and the impact is real. We’re talking about it at #AWHONN2025: Nourishing Bonds.Let us know if you're attending:

Another full month ahead—and we’re especially excited to be apart of the AWHONN Convention. Dr. Forbes will be presenting alongside our friend and expert, Dixie Weber. Will you be attending? Let us know—we’d love to connect!

Myth! Babies can experience NOWS (Neonatal Opioid Withdrawal Syndrome) even when their mothers are taking prescribed medications like methadone or buprenorphine as part of treatment. This is not a sign of misuse, it’s a known and expected effect of medication-assisted treatment.

More research, same message: 💊 Buprenorphine in pregnancy = better outcomes. Head to the link in our bio to read the full article.

Dr. Forbes is back on the road, delivering vital SEI education to healthcare teams across the Midwest. 🗓️ Now booking summer training dates. Want to bring this to your team? Reach out: info@nascend.com

We’re excited for Dr. Forbes to be speaking this morning at the Synova NICU Leadership Breakfast Symposium. Thanks to everyone joining us bright and early to advance care and drive better outcomes for opioid-exposed infants. We’re proud to be part of this important conversation.

We had a huge turnout for two amazing dinners focused on advancing care through nutrition for substance-exposed infants. Thank you to the incredible reps who helped make these events happen!

If you haven't heard! 🎉🎉 Dr. Forbes will be speaking at 2025 NICU Leadership Forum on Apr 27 - May 01, 2025. We would love to see you there! - via #Whova Event Platform.

Big shoutout to the amazing reps in Costa Mesa, Arcadia, Long Beach, Rancho Cucamonga, Valencia, and Fresno who brought us in — your sites were engaged, energized, and ready to elevate care. You’re leading the way! .Now’s the time to get your team up to speed — schedule with us!

Join me for Beyond the Status Quo: Elevating Neonatal Care for Opioid-Exposed Infants and let’s rewrite the narrative—one hospital, one provider, one newborn at a time. #SYNOVANICU #NICU #NeonatalCare #OpioidCrisis #HealthcareInnovation #ForbesOEI #NASCEND

Fact! A high-pitched, inconsolable cry is one of the most recognizable signs of withdrawal. Nurses who care for these babies will tell you—it’s a sound you never forget. Ready to improve care for opioid-exposed infants? Let’s make a change together—reach out to us today.

You may have heard of xylazine by its street name, 'tranq.' This powerful veterinary tranquilizer is increasingly found in illicit opioids like fentanyl, raising serious concerns about in-utero substance exposure and its impact on newborns. Source: NIH-NIDA, AAP

Stop the Stigma 🛑 Fact! Opioid use, whether prescribed or misused, can lead to neonatal opioid withdrawal syndrome in newborns. NASCEND's comfort-first approach has been proven to decrease the need for medication and reduces further opioid exposure for these infants.